A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Clinical trial NCT06884085 · COMPLETED

Trial details

NCT number: NCT06884085
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Hypertension

Start date: 2025-07-12
Primary completion: 2025-08-13
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.